Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.
about
Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugatesImmunogenicity of Vibrio vulnificus capsular polysaccharides and polysaccharide-protein conjugatesEndotoxin-mediated endothelial cell injury and activation: role of soluble CD14.Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection.Role of capsule and O antigen in the virulence of uropathogenic Escherichia coli.The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.Phase 1 testing of detoxified LPS/group B meningococcal outer membrane protein vaccine with and without synthetic CPG 7909 adjuvant for the prevention and treatment of sepsisOuter membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum.Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipopolysaccharide-induced activation and injury.
P2860
Q33595722-811AF993-BDF9-444D-8F10-2A0C21AFDF3CQ33596872-BB79A971-AE4D-4370-A9E6-305C32891D99Q33604205-53FA5B9F-2C16-4C19-935E-2C9AB7D9DC57Q34526632-F92F0C83-E3C7-4CF3-A4EC-994F77C16862Q35145454-380DDD60-FCFD-4381-B9BB-FA546742BFF2Q35821829-5FA1BA13-BD92-4BCE-877E-F78AA106BB7EQ36372619-B2F5EAC2-D48E-48F8-BA91-4C0B42ADE71BQ39515501-77715951-8DB5-469F-8466-3D158D2C13FAQ40375309-B8A8AA6D-F4DE-4F70-B2BB-8A23A510DF4B
P2860
Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Synthesis and characterization ...... saccharide conjugate vaccines.
@en
type
label
Synthesis and characterization ...... saccharide conjugate vaccines.
@en
prefLabel
Synthesis and characterization ...... saccharide conjugate vaccines.
@en
P2093
P2860
P1476
Synthesis and characterization ...... ysaccharide conjugate vaccines
@en
P2093
P2860
P304
P407
P577
1990-02-01T00:00:00Z